O.N. Diagnostics, LLC

O.N. Diagnostics develops non-invasive diagnostic applications for bone health and fracture risk assessment. The company's FDA-cleared VirtuOst® technology performs Biomechanical Computed Tomography (BCT) analysis, providing comprehensive measurements of bone mineral density and bone strength using existing CT scans of the hip or spine without requiring additional radiation, special imaging protocols, or calibration phantoms. VirtuOst identifies patients with osteoporosis and high-risk osteopenia, supporting clinical decision-making in patient care while enabling research applications in clinical trials, drug development, and medical device design. Since 2005, the company has maintained leadership in clinical bone assessment research and collaborates with academic and industry partners internationally.